Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Budesonide (oral use)

EU orphan designation number: EU/3/06/413   
Active ingredient: Budesonide (oral use)
Indication: Treatment of Graft-versus-Host disease
Sponsor: Dr Falk Pharma GmbH
Leinenweberstraße 5, 79041 Freiburg im Breisgau, Deutschland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
07/11/2006 Orphan designation EMEA/OD/049/06 (2006)5372 of 03/11/2006
22/12/2006 Corrigendum (2006)5372 of 03/11/2006